Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entrectinib and Midazolam PK Interaction in Solid Tumors
NCT03330990Phase 1Completed
- Sponsor
- Roche
- Start
- Nov 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of entrectinib in solid tumor, sponsored by Roche. Primary endpoints: Area Under the Curve to the Last Measurable Concentration at 4 weeks, Area Under the Curve to Infinity at 4 weeks and 3 more. Started Nov 2017; status: completed.
02
Drugs
entrectinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03330990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330990.